

The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: Wellness products (oils, gummies, topicals) Medical uses (pain, anxiety, epilepsy) Increasing consumer acceptance and retail availability SCOTTSDALE, AZ / ACCESS Newswire / May 5, 2026 / CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to announce our latest product CBD Pouches that are Nicotine Free.

SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding Inc. Under the terms of this agreement, CBD Life Sciences Inc. has purchased 100% of the issued and outstanding stock of Mushroom Madness Inc. and Formrunner Apparel. This strategic acquisition ensures that both Mushroom Madness Inc. and Formrunner Apparel are now fully wholly owned subsidiaries of CBD Life Sciences Inc. (CBDL).

The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: Wellness products (oils, gummies, topicals) Medical uses (pain, anxiety, epilepsy) Increasing consumer acceptance and retail availability SCOTTSDALE, AZ / ACCESS Newswire / April 21, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the launch of our New CBD Patches.

The natural, functional mushroom market is experiencing rapid growth, projected to exceed USD 60 billion by 2030, driven by rising demand for immunity-boosting, plant-based, and wellness products. Key trends include the dominance of Reishi, Lion's Mane, and Cordyceps in extracts and dietary supplements, alongside a high preference for locally sourced, fresh gourmet varieties.

With the global functional mushroom market projected to exceed $30+ billion and forecasted to grow at an estimated 9-12% CAGR, this strategic Bronx, New York distribution expansion positions CBDL to capture accelerating consumer demand, drive repeat retail velocity, and unlock scalable, high-margin revenue channels. SCOTTSDALE, ARIZONA / ACCESS Newswire / February 3, 2026 / CBD Life Sciences Inc. (OTC:CBDL), a fast-growing wellness and cannabinoid company focused on premium, trend-driven consumer products, today announced that Smoking Scholars, a well-established dispensary located in the Bronx, New York, has expanded its relationship with the Company to become a major distributor of CBDL's Dubai Mushroom Chocolate - one of the most in-demand functional wellness confections currently gaining traction across dispensary and specialty retail channels.

With the global pain management market projected to exceed $110 billion by 2030 and hemp-derived topical products continuing to post double-digit annual growth, CBD Life Sciences is accelerating its expansion into premium, high-traffic retail environments nationwide. SCOTTSDALE, ARIZONA / ACCESS Newswire / January 6, 2026 / CBD Life Sciences Inc. (OTC:CBDL), a fast-growing innovator in hemp-derived wellness and pain relief solutions, today announced it has secured Mother Earth Juice Bar as a new retail client for its 8000MG Hemp Pain Relief Cream, marking a strategic expansion into New York City through John F.

With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR, CBDL positions itself for major East Coast expansion amid surging consumer demand for natural relief solutions. SCOTTSDALE, AZ / ACCESS Newswire / November 18, 2025 / CBD Life Sciences Inc. (OTC:CBDL), the parent company of The CBD Vault, proudly announces the official launch of its Tremendous Anti-Inflammatory Soothe Gel, now offered at two premier Red Hots Spa locations in New York: Red Hots Spa - Garden City Hotel 45 7th Street, Garden City, NY 11530 Red Hots Spa - Roslyn, NY 1500 Old Northern Blvd, Floor 2, Roslyn, NY 11576 This marks a significant East Coast retail expansion for CBDL, aligning the company with one of New York's top luxury spa chains while tapping into the booming nationwide demand for fast-acting natural pain relief.

With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market. SCOTTSDALE, ARIZONA / ACCESS Newswire / November 12, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL) proudly announces another significant order from Smoking Scholars, the rapidly growing dispensary located in the Bronx, New York - further solidifying CBDL's position as one of the most active and fast-expanding players in the cannabis and CBD marketplace.